Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3679228 | 0.82 | ALDH1A1 (0.35) | NPSR1POLBDRD2CA12CA1 | |
| SCHEMBL36153 | 0.81 | TRPA1 (0.42) | TRPA1DRD2CA12CA1CA9 | |
| SCHEMBL38658450 | 0.80 | NPSR1 (0.37) | NPSR1POLBTRPA1DRD2MAPT | |
| SCHEMBL36605 | 0.78 | CA12 (0.38) | CA12CA1CA9 | |
| SCHEMBL25365134 | 0.77 | TRPA1 (0.50) | TRPA1DRD2MAPTATM | |
| SCHEMBL30540735 | 0.77 | TRPA1 (0.50) | TRPA1DRD2MAPTATM | |
| SCHEMBL7332445 | 0.76 | PPARA (0.32) | NPSR1POLB | |
| SCHEMBL16418139 | 0.73 | ALDH1A1 (0.37) | NPSR1POLBDRD2MAPT | |
| SCHEMBL30540736 | 0.73 | DRD2 (0.42) | TRPA1DRD2 | |
| SCHEMBL25366327 | 0.73 | DRD2 (0.40) | TRPA1DRD2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117987-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2021-09-14 | — | — | US | disclosed |
| US-11028195-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2021-06-08 | — | — | US | disclosed |
| US-20190322777-A1 | Hydroxyaryl Functionalized Polymers | BRIDGESTONE CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
| US-20190233557-A1 | Hydroxyaryl Functionalized Polymers | BRIDGESTONE CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-10227425-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2019-03-12 | — | — | US | disclosed |
| EP-2448900-B1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORP (JP) | 2017-04-26 | — | — | EP | disclosed |
| EP-2937365-B1 | METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS | BRIDGESTONE CORP (JP) | 2016-12-14 | — | — | EP | disclosed |
| EP-2589611-B1 | Method for making hydroxyaryl functionalized polymers | BRIDGESTONE CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-9365660-B2 | Anionic polymerization initiators and processes | BRIDGESTONE CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| EP-2937365-A1 | METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS | Bridgestone Corporation (JP) | 2015-10-28 | — | — | EP | disclosed |
| EP-2231719-B1 | HYDROXYARYL FUNCTIONALIZED POLYMERS | BRIDGESTONE CORP (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-20150141582-A1 | Hydroxyaryl Functionalized Polymers | BRIDGESTONE CORPORATION (JP) | 2015-05-21 | — | — | US | disclosed |
| US-8871871-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| EP-2589611-A1 | Hydroxyaryl functionalized polymers | Bridgestone Corporation (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-20120136128-A1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| EP-2448900-A2 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | Bridgestone Corporation (JP) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011008501-A2 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | BRIDGESTONE CORPORATION (JP) | 2011-01-20 | — | — | WO | disclosed |
| US-20100286348-A1 | HYDROXYARYL FUNCTIONALIZED POLYMERS | BRIDGESTONE CORPORATION (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-2231719-A2 | HYDROXYARYL FUNCTIONALIZED POLYMERS | Bridgestone Corporation (JP) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009086490-A2 | HYDROXYARYL FUNCTIONALIZED POLYMERS | BRIDGESTONE CORPORATION (JP) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322777-A1 | Hydroxyaryl Functionalized Polymers | HAAO, HCAR3, VCL | NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885 |
| US-11028195-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | NPSR1 2277/4885POLB 2551/4885TRPA1 2609/4885 |
| US-10227425-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885 |
| US-20120136128-A1 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES | AP1M1, AP2M1, CCNE2 | NPSR1 1981/4885POLB 762/4885TRPA1 570/4885 |
| US-20150141582-A1 | Hydroxyaryl Functionalized Polymers | HAAO, HCAR3, VCL | NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885 |
| US-20100286348-A1 | HYDROXYARYL FUNCTIONALIZED POLYMERS | HAAO, HCAR3, VCL | NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885 |
| US-11117987-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885 |
| US-20190233557-A1 | Hydroxyaryl Functionalized Polymers | HAAO, HCAR3, VCL | NPSR1 2277/4885POLB 2551/4885TRPA1 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.